×

Human anti-IL-23 antibodies, compositions, methods and uses

  • US 10,030,070 B2
  • Filed: 09/01/2017
  • Issued: 07/24/2018
  • Est. Priority Date: 12/29/2005
  • Status: Active Grant
First Claim
Patent Images

1. An isolated IL-23p19 antibody fragment, comprising a light chain variable region and a heavy chain variable region, said light chain variable region comprising:

  • a complementarity determining region light chain 1 (CDRL1) amino acid sequence of SEQ ID NO;

    50;

    a CDRL2 amino acid sequence of SEQ ID NO;

    56; and

    a CDRL3 amino acid sequence of SEQ ID NO;

    73,said heavy chain variable region comprising;

    a complementarity determining region heavy chain 1 (CDRH1) amino acid sequence of SEQ ID NO;

    5;

    a CDRH2 amino acid sequence of SEQ ID NO;

    20; and

    a CDRH3 amino acid sequence of SEQ ID NO;

    44.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×